GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

Gerresheimer GXI.DE · EUR

Health Care · XETRA · 🇩🇪 Germany

Compare

31.00

-0.64%

Close of 9 Nov 2026, in EUR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Gerresheimer

Its shares trade on XETRA under the ticker GXI.DE. It has been listed since 11 June 2007. In the fiscal year to 30 November 2025, it reported revenue of €2.32bn and a net loss of €320.3m. At that date it held total assets of €4.49bn and shareholders' equity of €1.08bn.

Gerresheimer AG manufactures and supplies glass and plastic products for the pharmaceutical and healthcare industry. The company is headquartered in Dusseldorf, Nordrhein-Westfalen. The company went IPO on 2007-06-11. The company operates through two business segments: Plastics and Devices, and Primary Packaging Glass. The Plastics and Devices segment produces standard and customized products for drug delivery, such as insulin pens, inhalers, and prefillable syrings. The Primary Packaging Glass segment focuses on the production of packaging of glass for medicines and cosmetics, such as pharmaceuticals jars, ampoules, injection vials, cartridges, perfume flacons and cream jars, as well as glass containers for the food and beverage industry. The firm operates approximately 40 production facilities in Europe, North America, South America and Asia.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Life Sciences Tools & Services
Listed since
11 Jun 2007
Employees
9,899

Leadership

Pay as last reported

  • Ms. Katja SchnitzlerMember of the Supervisory Board€110,000
  • Dr. Axel HerbergIndependent Chairman of the Supervisory Board, since 1996€293,000
  • Mr. Dietmar SiemssenChairman of the Management Board, Chief Executive Officer€3.4m
  • Mr. Markus RoemerDeputy Chairman of the Supervisory Board, since 2024
  • Mr. Wolf LehmannChief Financial Officer, Member of the Management Board
  • Dr. Lukas BurkhardtMember of the Management Board, Responsible for the Primary Packaging Glass Division€2.1m
  • Ms. Andrea AbtIndependent Member of the Supervisory Board€120,273
  • Dr. Sidonie Golombowski-DaffnerIndependent Member of the Supervisory Board€57,126
  • Prof. Dr. Annette KoehlerIndependent Member of the Supervisory Board€141,781
  • Dr. Dorothea WenzelIndependent Director, Member of the Supervisory Board€56,016
  • Dr. Christoph ZindelIndependent Member of the Supervisory Board€40,235
  • Mr. Robert FroehlerMember of the Supervisory Board€80,000

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
89
Environment
99
Social
99
Governance
68
Direct emissions (scope 1)
256,418 t
Energy emissions (scope 2)
322,543 t
Value chain emissions (scope 3)
1,302,738 t
Women in the workforce
35.2%
Carbon reduction policy
Yes
Human rights policy
Yes

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Gerresheimer AG possesses several strengths that contribute to its success in the market. These include:

Weaknesses

  • Despite its strengths, Gerresheimer AG also faces certain weaknesses that could hinder its growth and competitiveness. These weaknesses include:

Opportunities

  • Gerresheimer AG can capitalize on several opportunities to further enhance its market position and profitability. These opportunities include:

Threats

  • Gerresheimer AG must also be aware of the potential threats that could impact its business operations and market position. These threats include:

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.